Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2
Clinical trial NCT04222985 · TERMINATED
Trial details
- NCT number
- NCT04222985
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2021-05-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.